Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Unknown 3Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 6Thoracic 3Head & Neck 3Breast 2Gynecologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Nasopharyngeal Carcinoma 1Head and Neck Neoplasms 1

Interventions

Cisplatin 108Radiotherapy 45Docetaxel 44Radiotherapy, Intensity-Modulated 36Gemcitabine 31Fluorouracil 30camrelizumab 24toripalimab 21Drug Therapy 21Cetuximab 20apatinib 19Paclitaxel 16Carboplatin 16pembrolizumab 14Chemoradiotherapy 14Capecitabine 13Blood Specimen Collection 13sintilimab 12nimotuzumab 12Surveys and Questionnaires 10Surgical Procedures, Operative 10Endostatins 10Cyclophosphamide 9nedaplatin 8endostar protein 8durvalumab 8Nivolumab 8Neoadjuvant Therapy 8Induction Chemotherapy 8fludarabine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × lobaplatin × Head & Neck × Clear all
NCT06170697 2023-12-20

Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell Carcinoma

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Unknown
46 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT03210389 2017-07-06

A Clinical Trial of Chemotherapy With Lobaplatin and 5-FU in Recurrent Local or Distant Advanced NPC.

Sun Yat-sen University

Phase 2 Unknown
60 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT03117257 2017-04-17

Docetaxel and Loplatin Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced SCCHN

Guiyang Medical University

Phase 2 Unknown
144 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡